Literature DB >> 1383690

A limited set of SH2 domains binds BCR through a high-affinity phosphotyrosine-independent interaction.

A J Muller1, A M Pendergast, M H Havlik, L Puil, T Pawson, O N Witte.   

Abstract

SH2 (src homology region 2) domains are implicated in protein-protein interactions involved in signal transduction pathways. Isolated SH2 domains bind proteins that are tyrosine phosphorylated. A novel, phosphotyrosine-independent binding interaction between BCR, the Philadelphia chromosome breakpoint cluster region gene product, and the SH2 domain of its translocation partner c-ABL has recently been reported. We have examined the ability of additional SH2 domains to bind phosphotyrosine-free BCR and compared this with their ability to bind tyrosine-phosphorylated c-ABL 1b. Of 11 individual SH2 domains examined, 8 exhibited relatively high affinity for c-ABL 1b, whereas only 4 exhibited relatively high affinity for BCR. Binding of tyrosine-phosphorylated c-ABL 1b by the relatively high-affinity ABL and ARG SH2 domains was quantitatively analyzed, and equilibrium dissociation constants for both interactions were estimated to be in the range of 5 x 10(-7) M. The ABL SH2 domain exhibited relatively high affinity for phosphotyrosine-free BCR as well; however, this interaction appears to be about two orders of magnitude weaker than binding of tyrosine-phosphorylated c-ABL 1b. The ARG SH2 domain exhibited relatively weak affinity for BCR and was determined to bind about 10-fold less strongly than the ABL SH2 domain. The ABL and ARG SH2 domains differ by only 10 of 91 amino acids, and the substitution of ABL-specific amino acids into either the amino- or carboxy-terminal half of the ARG SH2 domain was found to increase its affinity for BCR. We discuss these results in terms of a model which has been proposed for peptide binding by class I histocompatibility glycoproteins.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1383690      PMCID: PMC360442          DOI: 10.1128/mcb.12.11.5087-5093.1992

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  43 in total

1.  Point mutations in the abl SH2 domain coordinately impair phosphotyrosine binding in vitro and transforming activity in vivo.

Authors:  B J Mayer; P K Jackson; R A Van Etten; D Baltimore
Journal:  Mol Cell Biol       Date:  1992-02       Impact factor: 4.272

2.  Molecular cloning of cDNAs encoding the GAP-associated protein p190: implications for a signaling pathway from ras to the nucleus.

Authors:  J Settleman; V Narasimhan; L C Foster; R A Weinberg
Journal:  Cell       Date:  1992-05-01       Impact factor: 41.582

3.  Phosphorylation of GAP and GAP-associated proteins by transforming and mitogenic tyrosine kinases.

Authors:  C Ellis; M Moran; F McCormick; T Pawson
Journal:  Nature       Date:  1990-01-25       Impact factor: 49.962

4.  The noncatalytic src homology region 2 segment of abl tyrosine kinase binds to tyrosine-phosphorylated cellular proteins with high affinity.

Authors:  B J Mayer; P K Jackson; D Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-15       Impact factor: 11.205

5.  Phospholipase C gamma complexes with ligand-activated platelet-derived growth factor receptors. An intermediate implicated in phospholipase activation.

Authors:  D A Kumjian; A Barnstein; S G Rhee; T O Daniel
Journal:  J Biol Chem       Date:  1991-02-25       Impact factor: 5.157

6.  PDGF beta-receptor stimulates tyrosine phosphorylation of GAP and association of GAP with a signaling complex.

Authors:  D R Kaplan; D K Morrison; G Wong; F McCormick; L T Williams
Journal:  Cell       Date:  1990-04-06       Impact factor: 41.582

7.  BCR first exon sequences specifically activate the BCR/ABL tyrosine kinase oncogene of Philadelphia chromosome-positive human leukemias.

Authors:  A J Muller; J C Young; A M Pendergast; M Pondel; N R Landau; D R Littman; O N Witte
Journal:  Mol Cell Biol       Date:  1991-04       Impact factor: 4.272

8.  Evidence for regulation of the human ABL tyrosine kinase by a cellular inhibitor.

Authors:  A M Pendergast; A J Muller; M H Havlik; R Clark; F McCormick; O N Witte
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-01       Impact factor: 11.205

9.  A phosphatidylinositol-3 kinase binds to platelet-derived growth factor receptors through a specific receptor sequence containing phosphotyrosine.

Authors:  J A Escobedo; D R Kaplan; W M Kavanaugh; C W Turck; L T Williams
Journal:  Mol Cell Biol       Date:  1991-02       Impact factor: 4.272

10.  Catalysis of guanine nucleotide exchange on the CDC42Hs protein by the dbl oncogene product.

Authors:  M J Hart; A Eva; T Evans; S A Aaronson; R A Cerione
Journal:  Nature       Date:  1991-11-28       Impact factor: 49.962

View more
  22 in total

Review 1.  Na(+),K (+)-ATPase as a docking station: protein-protein complexes of the Na(+),K (+)-ATPase.

Authors:  Linda Reinhard; Henning Tidow; Michael J Clausen; Poul Nissen
Journal:  Cell Mol Life Sci       Date:  2012-06-14       Impact factor: 9.261

2.  The PTEN/MMAC1 tumor suppressor phosphatase functions as a negative regulator of the phosphoinositide 3-kinase/Akt pathway.

Authors:  X Wu; K Senechal; M S Neshat; Y E Whang; C L Sawyers
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-22       Impact factor: 11.205

3.  Chemical ligation of folded recombinant proteins: segmental isotopic labeling of domains for NMR studies.

Authors:  R Xu; B Ayers; D Cowburn; T W Muir
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-19       Impact factor: 11.205

4.  Phosphatidylinositol 3-kinase p85{alpha} subunit-dependent interaction with BCR/ABL-related fusion tyrosine kinases: molecular mechanisms and biological consequences.

Authors:  Shu-Yue Ren; Elisabeth Bolton; M Golam Mohi; Andrea Morrione; Benjamin G Neel; Tomasz Skorski
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

Review 5.  New insights into protein-tyrosine kinase receptor signaling complexes.

Authors:  M J Fry; G Panayotou; G W Booker; M D Waterfield
Journal:  Protein Sci       Date:  1993-11       Impact factor: 6.725

6.  Ras-GAP binding and phosphorylation by herpes simplex virus type 2 RR1 PK (ICP10) and activation of the Ras/MEK/MAPK mitogenic pathway are required for timely onset of virus growth.

Authors:  C C Smith; J Nelson; L Aurelian; M Gober; B B Goswami
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

7.  En bloc substitution of the Src homology region 2 domain activates the transforming potential of the c-Abl protein tyrosine kinase.

Authors:  A J Muller; A M Pendergast; K Parmar; M H Havlik; N Rosenberg; O N Witte
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

8.  Aberrant protein phosphorylation at tyrosine is responsible for the growth-inhibitory action of pp60v-src expressed in the yeast Saccharomyces cerevisiae.

Authors:  M Florio; L K Wilson; J B Trager; J Thorner; G S Martin
Journal:  Mol Biol Cell       Date:  1994-03       Impact factor: 4.138

9.  SH1 domain autophosphorylation of P210 BCR/ABL is required for transformation but not growth factor independence.

Authors:  A M Pendergast; M L Gishizky; M H Havlik; O N Witte
Journal:  Mol Cell Biol       Date:  1993-03       Impact factor: 4.272

10.  Phosphotyrosine (p-Tyr)-dependent and -independent mechanisms of p190 RhoGAP-p120 RasGAP interaction: Tyr 1105 of p190, a substrate for c-Src, is the sole p-Tyr mediator of complex formation.

Authors:  R W Roof; M D Haskell; B D Dukes; N Sherman; M Kinter; S J Parsons
Journal:  Mol Cell Biol       Date:  1998-12       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.